36C25022Q1053_1.docx
DOCX document 16 KB Posted
- Solicitation number
- 36C25022Q1053
View the file
Other files
| File | Type | Posted |
|---|---|---|
| AMEND - 36C25022Q1053 8-31 Revision.docx | DOCX document | |
| 36C25022Q1053.docx | DOCX document | |
| VHA PERMIT 13-11983-01.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Combined Synopsis/Solicitation Notice Combined Synopsis/Solicitation Notice
| SUBJECT* |
| Radio Pharma 5 YEAR ORDERING Period nd10.01 $125K |
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 46953 |
| SOLICITATION NUMBER* |
| 36C25022Q1053 |
| RESPONSE DATE/TIME/ZONE |
| 09-09-2022 13:00 EASTERN TIME, NEW YORK, USA |
| ARCHIVE |
| 60 DAYS AFTER THE RESPONSE DATE |
| RECOVERY ACT FUNDS |
| N |
SET-ASIDE
| PRODUCT SERVICE CODE* |
| 6505 |
| NAICS CODE* |
| 325412 |
CONTRACTING OFFICE ADDRESS
Department of Veterans Affairs Network Contracting Office 10 1700 E 38th Street Marion IN 46953
POINT OF CONTACT*
Contracting Officer Kellie J Konopinski kellie.konopinski@va.gov
PLACE OF PERFORMANCE
ADDRESS
POSTAL CODE
COUNTRY
ADDITIONAL INFORMATION
AGENCY’S URL
URL DESCRIPTION
AGENCY CONTACT’S EMAIL ADDRESS
EMAIL DESCRIPTION
DESCRIPTION
See attached document: VHA PERMIT 13-11983-01.
SCHEDULE OF SUPPLIES AND SERVICES
The Department of Veterans Affairs Northern Indiana Health Care System for the Fort Wayne Indiana Medical Center, Nuclear Medicine Service, requires the contractor/licensee to provide radiopharmaceuticals, on an as needed basis to be used with PET/CT imaging systems within Fort Wayne VAMC.
| Item # |
| RadioPharm |
| Product Name |
| Unit of Measure |
Volume Estimate (Avg/yr based on last 5 yrs annual usage)
| 1 |
| HDP Tc99m |
| Bone Scan |
| UD |
| 240 |
| 2 |
| PYP Kit |
| Red Blood Cell Tag |
| UD |
| 60 |
| 3 |
| Tc04 MUGA |
| Sodium Pertechnetate |
| UD |
| 60 |
| 4 |
| Tc04 Muga Consignment |
| Sodium Pertechnetate |
| UD |
| 60 |
| 5 |
| Tc99m |
| Tetrafosmin Myocardial Perfusion-Stress |
| UD |
| 840 |
| 6 |
| Tc99m |
| Tetrafosmin Myocardial Perusion-Rest |
| UD |
| 840 |
| 7 |
| Tc99m |
| Sulfur Colloid |
| UD |
| 60 |
| 8 |
| Tc-99m |
| Mebrofenin Hepatobilliary Scan |
| UD |
| 36 |
| 9 |
| Tc04 |
| Sodium Pertechnetate Calibration Source-Microcurie |
| UD |
| 540 |
| 10 |
| TI-201 |
| Chloride Myocardial Perfusion-Rest |
| UD |
| 60 |
| 11 |
| TI-201 |
| Chloride Myocardial Perfusion-Stress |
| UD |
| 60 |
| 12 |
| Tc04 |
| Sodium Pertechnetate Calibration Source Millicurie |
| UD |
| 540 |
| 13 |
| Tc04 |
| Sodium Pertechnetate Linearity |
| UD |
| 4 |
| 14 |
| N/A |
| Computer System/License |
| MO |
| 12 |
* Vendors are encouraged to list any additional line items they can provide, including new to market products and radiotracers that may provide a contingency source for other Nuclear Medicine Service modalities.
The vendor should be responsible for all lead and or other shielding used in the shipping of the radiopharmaceuticals, as lead is considered a hazardous waste. The vendor should agree to acknowledgement as to this hazard and agree to managing it in accordance with EPA and RCRA regulations.
| FAR Number |
| Title |
| Date |
| 52.219-33 |
| NONMANUFACTURER RULE |
| SEP 2021 |
| *= Required Field |
| Combined Synopsis/Solicitation Notice |
Combined Synopsis/Solicitation Notice
File details come from the government source that posted it. Updated .